List of Contributions

Dear Fellow Statisticians, We are pleased to invite you to the next seminar in the ISBS Webinar Series: From Data to Cure: Strategize Rare Disease & Precision Care Future Speaker: Luyan Dai, PhD Date: Friday, August 21, 2026 Time: 10:00 AM Eastern Time Rare disease drug development faces unique ...

Title: This Friday: WTASA Short Course on Hybrid Controlled Trials with External Controls | Shu Yang | Aug. 14 🎥 Cannot attend live? All registrants will receive the course recording and slides/materials afterward. Dear colleagues, A friendly reminder that the Western Tennessee ASA Chapter ...

📝 Title WTASA Short Course: Hybrid Controlled Trials with External Controls | Shu Yang | Aug. 14 🎥 Cannot attend live? All registrants will receive the course recording and slides/materials afterward. We are pleased to invite you to a WTASA short course featuring Professor Shu Yang of North ...

Final Announcement | This Friday Is RMST the future of survival analysis? If you're still relying on hazard ratios, it may be time to rethink. For decades, the hazard ratio (HR) has been the default tool in survival analysis. But: What happens when proportional hazards doesn't hold? How do we interpret ...

Dear Fellow Statisticians, We are pleased to announce an exciting upcoming seminar as part of the ISBS Webinar Series on clinical trial innovation. The seminar, titled "The Patient Voice in Focus: Advancing Early Phase Oncology Trials Through PRO-Driven Innovation," will be held on April 24, 2026, 11:00 ...